Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 58 | 2024 | 8863 | 5.180 |
Why?
|
Glioma | 32 | 2023 | 3401 | 4.300 |
Why?
|
Glioblastoma | 26 | 2024 | 3481 | 3.020 |
Why?
|
Meningeal Neoplasms | 10 | 2023 | 1241 | 2.100 |
Why?
|
Meningioma | 8 | 2023 | 1209 | 1.950 |
Why?
|
Magnetic Resonance Imaging | 54 | 2024 | 35421 | 1.660 |
Why?
|
Angiogenesis Inhibitors | 9 | 2021 | 2038 | 1.560 |
Why?
|
Isocitrate Dehydrogenase | 11 | 2023 | 871 | 1.310 |
Why?
|
Neoplasm Recurrence, Local | 15 | 2023 | 9239 | 1.010 |
Why?
|
Tumor Burden | 9 | 2023 | 1915 | 0.970 |
Why?
|
Glutarates | 2 | 2020 | 236 | 0.730 |
Why?
|
Central Nervous System Neoplasms | 3 | 2021 | 895 | 0.640 |
Why?
|
Artificial Intelligence | 6 | 2023 | 2214 | 0.560 |
Why?
|
Cranial Irradiation | 1 | 2019 | 401 | 0.550 |
Why?
|
Tomography, X-Ray Computed | 15 | 2023 | 20129 | 0.530 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2023 | 3327 | 0.530 |
Why?
|
Trauma Centers | 1 | 2020 | 890 | 0.510 |
Why?
|
Tyrosine | 1 | 2018 | 1461 | 0.480 |
Why?
|
Cervical Vertebrae | 1 | 2020 | 975 | 0.470 |
Why?
|
Wounds, Nonpenetrating | 1 | 2020 | 794 | 0.470 |
Why?
|
World Health Organization | 1 | 2019 | 1318 | 0.460 |
Why?
|
Iohexol | 1 | 2013 | 196 | 0.430 |
Why?
|
Radiosurgery | 3 | 2020 | 1329 | 0.430 |
Why?
|
Humans | 113 | 2024 | 744343 | 0.420 |
Why?
|
Spinal Cord Injuries | 1 | 2020 | 931 | 0.420 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2020 | 3760 | 0.400 |
Why?
|
Retrospective Studies | 39 | 2023 | 77449 | 0.400 |
Why?
|
Temporal Lobe | 1 | 2019 | 1670 | 0.390 |
Why?
|
Mutation | 15 | 2024 | 29786 | 0.390 |
Why?
|
Cerebellar Neoplasms | 3 | 2022 | 587 | 0.390 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 1624 | 0.370 |
Why?
|
Middle Aged | 48 | 2022 | 213383 | 0.340 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5221 | 0.310 |
Why?
|
Cerebral Angiography | 1 | 2013 | 1285 | 0.300 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2019 | 367 | 0.300 |
Why?
|
Adult | 44 | 2024 | 214055 | 0.300 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1082 | 0.290 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2019 | 1770 | 0.280 |
Why?
|
Combined Modality Therapy | 4 | 2020 | 8642 | 0.280 |
Why?
|
Diagnostic Imaging | 4 | 2022 | 3507 | 0.280 |
Why?
|
Young Adult | 24 | 2020 | 56430 | 0.280 |
Why?
|
Duodenal Diseases | 1 | 2007 | 102 | 0.280 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1184 | 0.280 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 1504 | 0.280 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2019 | 658 | 0.270 |
Why?
|
Diverticulum | 1 | 2007 | 136 | 0.270 |
Why?
|
Medulloblastoma | 2 | 2022 | 683 | 0.270 |
Why?
|
Central Nervous System Diseases | 2 | 2020 | 518 | 0.270 |
Why?
|
Prognosis | 14 | 2020 | 29063 | 0.260 |
Why?
|
Aged | 35 | 2022 | 163280 | 0.260 |
Why?
|
Aged, 80 and over | 21 | 2020 | 57776 | 0.260 |
Why?
|
Observer Variation | 4 | 2021 | 2593 | 0.250 |
Why?
|
Intestinal Perforation | 1 | 2007 | 253 | 0.250 |
Why?
|
Male | 48 | 2023 | 350118 | 0.250 |
Why?
|
Neoplasm, Residual | 2 | 2020 | 973 | 0.250 |
Why?
|
Female | 50 | 2022 | 380194 | 0.240 |
Why?
|
DNA Repair Enzymes | 2 | 2018 | 349 | 0.240 |
Why?
|
Brain | 8 | 2022 | 26385 | 0.240 |
Why?
|
Diffusion Magnetic Resonance Imaging | 5 | 2023 | 2737 | 0.230 |
Why?
|
Ovariectomy | 2 | 2003 | 661 | 0.220 |
Why?
|
Disease Progression | 8 | 2019 | 13284 | 0.220 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7913 | 0.220 |
Why?
|
Amnesia, Transient Global | 1 | 2022 | 22 | 0.210 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6234 | 0.210 |
Why?
|
Nandrolone | 1 | 2002 | 17 | 0.210 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.210 |
Why?
|
Melanoma | 1 | 2020 | 5510 | 0.210 |
Why?
|
Lymphoma | 2 | 2022 | 1877 | 0.210 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2022 | 89 | 0.210 |
Why?
|
Lung Neoplasms | 3 | 2021 | 13102 | 0.210 |
Why?
|
Follow-Up Studies | 12 | 2019 | 39050 | 0.210 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7659 | 0.190 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2022 | 1378 | 0.190 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3143 | 0.190 |
Why?
|
Optic Nerve | 1 | 2024 | 554 | 0.190 |
Why?
|
Spinal Cord Neoplasms | 1 | 2023 | 281 | 0.180 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3479 | 0.180 |
Why?
|
Discitis | 1 | 2020 | 40 | 0.180 |
Why?
|
Disease-Free Survival | 5 | 2020 | 6895 | 0.180 |
Why?
|
Ovarian Cysts | 1 | 2020 | 115 | 0.180 |
Why?
|
Infratentorial Neoplasms | 1 | 2020 | 94 | 0.170 |
Why?
|
Anabolic Agents | 1 | 2002 | 247 | 0.170 |
Why?
|
Intraoperative Period | 1 | 2020 | 520 | 0.170 |
Why?
|
Algorithms | 8 | 2024 | 13881 | 0.170 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4262 | 0.170 |
Why?
|
Dictionaries as Topic | 1 | 2018 | 12 | 0.170 |
Why?
|
Encephalitis | 1 | 2022 | 423 | 0.170 |
Why?
|
Cerebral Veins | 1 | 2019 | 156 | 0.160 |
Why?
|
Whole Body Imaging | 1 | 2020 | 280 | 0.160 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 536 | 0.160 |
Why?
|
Hemangioblastoma | 1 | 2018 | 70 | 0.160 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13695 | 0.150 |
Why?
|
Consensus | 6 | 2023 | 2959 | 0.150 |
Why?
|
Postoperative Period | 2 | 2020 | 1842 | 0.150 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2023 | 477 | 0.150 |
Why?
|
Facial Nerve | 1 | 2019 | 271 | 0.150 |
Why?
|
Survival Rate | 8 | 2019 | 12788 | 0.150 |
Why?
|
Contrast Media | 6 | 2020 | 5300 | 0.150 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2023 | 8949 | 0.140 |
Why?
|
Glycine | 1 | 2020 | 671 | 0.140 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 2734 | 0.140 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2003 | 852 | 0.140 |
Why?
|
Language | 2 | 2019 | 1471 | 0.140 |
Why?
|
Unnecessary Procedures | 1 | 2020 | 432 | 0.140 |
Why?
|
Perfusion | 1 | 2021 | 1360 | 0.140 |
Why?
|
Necrosis | 1 | 2020 | 1643 | 0.140 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2759 | 0.140 |
Why?
|
Reproducibility of Results | 9 | 2023 | 19905 | 0.140 |
Why?
|
Tibia | 1 | 2002 | 1077 | 0.140 |
Why?
|
Spinal Stenosis | 1 | 2019 | 255 | 0.130 |
Why?
|
Immunotherapy | 3 | 2023 | 4445 | 0.130 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 199 | 0.130 |
Why?
|
Survival Analysis | 4 | 2018 | 10252 | 0.130 |
Why?
|
Nervous System Neoplasms | 1 | 2015 | 91 | 0.130 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2016 | 0.130 |
Why?
|
Postoperative Care | 2 | 2019 | 1486 | 0.130 |
Why?
|
Chordoma | 1 | 2018 | 359 | 0.130 |
Why?
|
Dexamethasone | 1 | 2022 | 1951 | 0.130 |
Why?
|
Spine | 2 | 2020 | 1144 | 0.130 |
Why?
|
Lumbar Vertebrae | 2 | 2021 | 1848 | 0.130 |
Why?
|
Osteoporosis | 2 | 2003 | 1580 | 0.120 |
Why?
|
Skull Base Neoplasms | 1 | 2018 | 284 | 0.120 |
Why?
|
Proteomics | 3 | 2005 | 3638 | 0.120 |
Why?
|
Gallbladder Diseases | 1 | 2015 | 125 | 0.120 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15076 | 0.120 |
Why?
|
ROC Curve | 2 | 2020 | 3527 | 0.120 |
Why?
|
Sarcoidosis | 1 | 2019 | 506 | 0.120 |
Why?
|
Semantics | 1 | 2017 | 584 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2020 | 63114 | 0.120 |
Why?
|
Prospective Studies | 7 | 2023 | 53288 | 0.120 |
Why?
|
Retreatment | 1 | 2015 | 610 | 0.120 |
Why?
|
Cohort Studies | 7 | 2022 | 40561 | 0.120 |
Why?
|
Patient Admission | 1 | 2021 | 1380 | 0.110 |
Why?
|
Chromosome Deletion | 1 | 2018 | 1401 | 0.110 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2015 | 230 | 0.110 |
Why?
|
Neoplasms | 2 | 2019 | 21683 | 0.110 |
Why?
|
Synchrotrons | 2 | 2003 | 38 | 0.110 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12354 | 0.110 |
Why?
|
Spectrophotometry, Infrared | 2 | 2003 | 114 | 0.110 |
Why?
|
Facial Injuries | 1 | 2014 | 183 | 0.110 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 629 | 0.110 |
Why?
|
Gene Fusion | 1 | 2016 | 371 | 0.110 |
Why?
|
DNA Modification Methylases | 1 | 2013 | 206 | 0.110 |
Why?
|
Bone Density | 2 | 2003 | 3468 | 0.110 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2879 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2018 | 1462 | 0.110 |
Why?
|
Pattern Recognition, Automated | 2 | 2023 | 1005 | 0.100 |
Why?
|
Area Under Curve | 1 | 2016 | 1654 | 0.100 |
Why?
|
Facial Transplantation | 1 | 2014 | 226 | 0.100 |
Why?
|
Brain Diseases | 1 | 2021 | 1563 | 0.100 |
Why?
|
Salvage Therapy | 2 | 2018 | 1275 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2018 | 5172 | 0.100 |
Why?
|
Neurosurgical Procedures | 2 | 2019 | 2002 | 0.100 |
Why?
|
Brain Mapping | 3 | 2019 | 6669 | 0.100 |
Why?
|
Radiation Injuries | 1 | 2018 | 1180 | 0.100 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1095 | 0.100 |
Why?
|
Pyridines | 2 | 2020 | 2825 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1587 | 0.100 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14722 | 0.100 |
Why?
|
Adolescent | 10 | 2020 | 85781 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2016 | 838 | 0.090 |
Why?
|
Macaca fascicularis | 2 | 2003 | 915 | 0.090 |
Why?
|
Image Enhancement | 2 | 2018 | 2921 | 0.090 |
Why?
|
Subtraction Technique | 1 | 2012 | 525 | 0.080 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11031 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3064 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2020 | 2645 | 0.080 |
Why?
|
Robotics | 1 | 2015 | 899 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11524 | 0.080 |
Why?
|
Child | 9 | 2022 | 77709 | 0.080 |
Why?
|
Phenotype | 3 | 2020 | 16365 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4034 | 0.070 |
Why?
|
Lomustine | 2 | 2017 | 59 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4215 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3508 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3703 | 0.070 |
Why?
|
Structural Homology, Protein | 1 | 2005 | 91 | 0.070 |
Why?
|
Incidence | 2 | 2021 | 20947 | 0.070 |
Why?
|
Metalloproteins | 1 | 2005 | 100 | 0.060 |
Why?
|
Edema | 2 | 2023 | 789 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4042 | 0.060 |
Why?
|
Genomics | 4 | 2024 | 5720 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2016 | 3023 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12959 | 0.060 |
Why?
|
Carbonates | 1 | 2003 | 21 | 0.060 |
Why?
|
Preoperative Care | 1 | 2013 | 2250 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4838 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6538 | 0.060 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2003 | 164 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3597 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 9959 | 0.060 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2849 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2017 | 3772 | 0.050 |
Why?
|
Propensity Score | 2 | 2019 | 1781 | 0.050 |
Why?
|
Solubility | 1 | 2003 | 1085 | 0.050 |
Why?
|
Genotype | 1 | 2016 | 12951 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 503 | 0.050 |
Why?
|
Diffusion | 1 | 2023 | 833 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.050 |
Why?
|
Infarction | 1 | 2022 | 244 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 299 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1801 | 0.050 |
Why?
|
Animals | 8 | 2023 | 168757 | 0.050 |
Why?
|
Nerve Net | 1 | 2013 | 2174 | 0.050 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2003 | 386 | 0.050 |
Why?
|
Child, Preschool | 5 | 2020 | 41006 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 644 | 0.040 |
Why?
|
Bone Remodeling | 1 | 2003 | 575 | 0.040 |
Why?
|
Philadelphia | 1 | 2020 | 266 | 0.040 |
Why?
|
Rhode Island | 1 | 2020 | 347 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4286 | 0.040 |
Why?
|
DNA Helicases | 1 | 2024 | 859 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 711 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2019 | 520 | 0.040 |
Why?
|
Electric Power Supplies | 1 | 2018 | 99 | 0.040 |
Why?
|
Software | 1 | 2012 | 4443 | 0.040 |
Why?
|
Rare Diseases | 1 | 2022 | 553 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1107 | 0.040 |
Why?
|
Cranial Fossa, Posterior | 1 | 2018 | 139 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 802 | 0.040 |
Why?
|
Negotiating | 1 | 2018 | 133 | 0.040 |
Why?
|
Benchmarking | 1 | 2024 | 1042 | 0.040 |
Why?
|
Caenorhabditis elegans | 2 | 2003 | 1419 | 0.040 |
Why?
|
Automation | 1 | 2019 | 584 | 0.040 |
Why?
|
Neuroendoscopy | 1 | 2018 | 105 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 426 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 841 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2699 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 627 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1266 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2018 | 395 | 0.030 |
Why?
|
Bone and Bones | 2 | 2003 | 2575 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 1917 | 0.030 |
Why?
|
Preoperative Period | 1 | 2017 | 549 | 0.030 |
Why?
|
Proteome | 2 | 2003 | 1799 | 0.030 |
Why?
|
United States | 2 | 2020 | 69872 | 0.030 |
Why?
|
Gadolinium | 1 | 2020 | 952 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12245 | 0.030 |
Why?
|
Meglumine | 1 | 2015 | 149 | 0.030 |
Why?
|
Collagen | 1 | 2003 | 2689 | 0.030 |
Why?
|
Estrogens | 1 | 2002 | 1566 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2018 | 780 | 0.030 |
Why?
|
Genome | 1 | 2003 | 1808 | 0.030 |
Why?
|
Carmustine | 1 | 2014 | 137 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2019 | 523 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 496 | 0.030 |
Why?
|
Anilides | 1 | 2017 | 408 | 0.030 |
Why?
|
Information Dissemination | 1 | 2022 | 1099 | 0.030 |
Why?
|
China | 1 | 2020 | 2248 | 0.030 |
Why?
|
Craniotomy | 1 | 2018 | 729 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2017 | 664 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1265 | 0.030 |
Why?
|
Gene Expression | 2 | 2003 | 7799 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6364 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3588 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2309 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3462 | 0.030 |
Why?
|
Histones | 1 | 2023 | 2599 | 0.030 |
Why?
|
Software Validation | 1 | 2012 | 59 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 3508 | 0.030 |
Why?
|
Functional Laterality | 1 | 2019 | 2290 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2015 | 665 | 0.020 |
Why?
|
Neurosurgery | 1 | 2018 | 643 | 0.020 |
Why?
|
Seizures | 1 | 2024 | 2859 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3474 | 0.020 |
Why?
|
Peptides | 1 | 2003 | 4409 | 0.020 |
Why?
|
Escherichia coli | 1 | 2003 | 4217 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2265 | 0.020 |
Why?
|
Quinazolines | 1 | 2017 | 1356 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3586 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1584 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6314 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2029 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2924 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3798 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5853 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4803 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2133 | 0.020 |
Why?
|
Infant | 2 | 2020 | 35136 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2013 | 1758 | 0.020 |
Why?
|
Rest | 1 | 2013 | 901 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10943 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4851 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2649 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4420 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 6103 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6756 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8663 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2005 | 144 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9274 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2003 | 18029 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81183 | 0.020 |
Why?
|
Sequence Analysis, Protein | 1 | 2005 | 258 | 0.020 |
Why?
|
Decision Making | 1 | 2018 | 3887 | 0.020 |
Why?
|
Transcription Factors | 1 | 2024 | 12208 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.010 |
Why?
|
DNA, Helminth | 1 | 2003 | 34 | 0.010 |
Why?
|
Models, Molecular | 2 | 2005 | 5456 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13989 | 0.010 |
Why?
|
Databases, Protein | 1 | 2005 | 383 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 25043 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5078 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 255 | 0.010 |
Why?
|
Purine Nucleosides | 1 | 2002 | 30 | 0.010 |
Why?
|
Genes, Helminth | 1 | 2003 | 147 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11483 | 0.010 |
Why?
|
Helminth Proteins | 1 | 2003 | 171 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11366 | 0.010 |
Why?
|
Gene Order | 1 | 2002 | 176 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5867 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 2002 | 420 | 0.010 |
Why?
|
Computational Biology | 2 | 2005 | 3521 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9856 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2005 | 2011 | 0.010 |
Why?
|
Introns | 1 | 2003 | 991 | 0.010 |
Why?
|
Databases as Topic | 1 | 2002 | 475 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 25625 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2005 | 3129 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2003 | 810 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23338 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 2050 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2003 | 1117 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 2839 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4320 | 0.010 |
Why?
|
Exons | 1 | 2003 | 2437 | 0.010 |
Why?
|
Binding Sites | 1 | 2005 | 6114 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1783 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 2206 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3846 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 72290 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.010 |
Why?
|
Protein Binding | 1 | 2005 | 9386 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2002 | 1940 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15295 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13815 | 0.010 |
Why?
|
Hippocampus | 1 | 2002 | 3675 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 18111 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2002 | 3848 | 0.010 |
Why?
|
Epilepsy | 1 | 2002 | 3310 | 0.000 |
Why?
|